Clinical trials - Press Releases

Date	Title	Company
17-Nov-2023	UK industry clinical trial performance shows signs of improvement, says ABPI report	ABPI
15-Nov-2023	Landmark Clinical Trial Redefines Multidrug-Resistant Tuberculosis Treatment Options	Médecins Sans Frontières/ MSF's
15-Nov-2023	SciRhom Files Clinical Trial Application for First-in-Human Trials of Novel Antibody Against Autoimmune Diseases	SciRhom
14-Nov-2023	Glox Therapeutics Secures £4.3M Seed Funding to Develop Precision Antimicrobials Targeting Drug-resistant Bacteria	Glox Therapeutics
14-Nov-2023	PureTech's LYT-300 (Oral Allopregnanolone) Achieved Primary Endpoint in a Phase 2a Acute Anxiety Trial in Healthy Volunteers	PureTech Health plc
14-Nov-2023	The Revolutionary Era of Liquid Biopsy: A Non-Invasive Approach to Precision Medicine	Roots Analysis
13-Nov-2023	Bloomsbury Genetic Therapies Celebrates its One Year Anniversary and Outlines Key Strategic and Operational Achievements since Launch	Bloomsbury Genetic Therapies
13-Nov-2023	Resolution Therapeutics’ founders present clinical proof-of-concept for macrophage cell therapy in end-stage liver disease at AASLD	Resolution Therapeutics Limited
09-Nov-2023	Phesi launches Patient Access Score for clinical trial sponsors to enhance investigator selection and accelerate patient recruitment	Phesi
09-Nov-2023	Lindus Health and Pharmanovia announce enrolment of first patient in new clinical trial to explore the treatment of severe insomnia in hard-to-reach patients	Lindus Health and Pharmanovia
09-Nov-2023	Lytix Biopharma presents third quarter 2023 results	Lytix
09-Nov-2023	HUTCHMED Announces that Takeda Receives U.S. FDA Approval of FRUZAQLA™ (fruquintinib) for Previously Treated Metastatic Colorectal Cancer	HUTCHMED
07-Nov-2023	Ground-breaking treatment for Alcohol Use Disorder shown to halve alcohol consumption amongst heavy drinkers in three months at phase II: a new hope for patients	Kinnov Therapeutics
06-Nov-2023	Zibotentan/dapagliflozin combination demonstrated significant albuminuria reduction in patients with chronic kidney disease and proteinuria in ZENITH-CKD Phase IIb trial	AstraZeneca
02-Nov-2023	Novotech Releases In-Depth 2023 Global Clinical Trial Landscape Reports on Hemophilia and Primary Biliary Cholangitis	Novotech
01-Nov-2023	Anaveon announces presentation of ANV600 preclinical data supporting combination therapy with therapeutic PD-1 inhibitors	Anaveon
31-Oct-2023	Nouscom’s Off-the-Shelf Cancer Vaccine, NOUS-209, Shows Potential to ‘Intercept’ Cancer in Subjects with Lynch Syndrome	Nouscom
31-Oct-2023	LEO Pharma announces positive outcome of DELTA 3 open-label extension trial of delgocitinib cream in the treatment of adults with moderate to severe chronic hand eczema (CHE)	LEO Pharma
31-Oct-2023	Elligo and Avallano Launching Patient-First, AI-Powered Clinical Trials Ecosystem	Elligo Health Research®
26-Oct-2023	Phastar Offers Pro Bono Support to Medicines Development for Global Health	Phastar